fbpx

ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

The Lundbeck Foundation awards a record number of fellowships
6. November 2019
Febrile seizures in small children to be fully investigated
1. November 2019
The Lundbeck Foundation gives grants worth DKK 100 million to 20 experienced scientists
24. October 2019